You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
心脈醫療(688016.SH):截至4月,整體銷售量及植入已按照公司預期計劃進行
格隆匯 05-09 15:13

格隆匯5月9日丨心脈醫療(688016.SH)於2023年5月4日召開2023年第一季度報吿業績電話會,就“公司創新產品在一季度的收入佔比多少?以及3、4月收入中有多少來自擇期手術的滯後?”,公司表示,報吿期內,創新產品Castor分支型主動脈覆膜支架及輸送系統約佔收入30%以上,Minos腹主動脈覆膜支架及輸送系統約佔收入15%左右。

春節後整體手術量開始恢復,胸主動脈植入量佔比較高,整體是胸主的高峯期,3月開始腹主動脈植入量增多,4月已經恢復到疫情前狀態。截至4月,整體銷售量及植入已按照公司預期計劃進行。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account